China First: Beijing's Bolstering Of Generics Rekindles IPR Fears

 
• By Brian Yang
  
Yuyang garden
China policy shift on generics to generate big impact on MNCs
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from China

More from Asia